Last reviewed · How we verify
NCT03867773
Time Restricted Feeding (4-hour Versus 6-hour) for Weight Loss in Obese Adults
NA trial testing Time restricted feeding in Obesity in 82 participants. Completed in 30 October 2019.
30 October 2019
Quick facts
| Lead sponsor | University of Illinois at Chicago |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 82 |
| Start date | 1 February 2019 |
| Primary completion | 30 October 2019 |
| Estimated completion | 30 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Time restricted feeding
Conditions studied
Sponsor
University of Illinois at Chicago
Who can join
Adults 18 to 65, any sex, with Obesity or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of this proposal are to compare the effects of 4-h versus 6-h time restricted feeding (TRF) on body weight and metabolic disease risk factors in adults with obesity. To test the study objectives, a 10-week randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 2-week baseline period; and (2) 8-week TRF weight loss period, will be implemented. Obese subjects will be randomized to 1 of 3 groups: (1) 4-h TRF, (2) 6-h TRF, or a no-intervention control group. This study will be the first randomized controlled trial to compare 4-h versus 6-h TRF.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of 4- and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity.
Cienfuegos S, Gabel K, Kalam F, Ezpeleta M, et al · · 2020 · cited 424× · PMID 32673591 · DOI 10.1016/j.cmet.2020.06.018 -
Dietary regulation in health and disease.
Wu Q, Gao ZJ, Yu X, Wang P. · · 2022 · cited 98× · PMID 35871218 · DOI 10.1038/s41392-022-01104-w -
The effect of 4-h versus 6-h time restricted feeding on sleep quality, duration, insomnia severity and obstructive sleep apnea in adults with obesity.
Cienfuegos S, Gabel K, Kalam F, Ezpeleta M, et al · · 2022 · cited 45× · PMID 33759620 · DOI 10.1177/02601060211002347 -
Effects of Intermittent Fasting in Human Compared to a Non-intervention Diet and Caloric Restriction: A Meta-Analysis of Randomized Controlled Trials.
Gu L, Fu R, Hong J, Ni H, et al · · 2022 · cited 38× · PMID 35586738 · DOI 10.3389/fnut.2022.871682 -
Effect of time-restricted eating on sex hormone levels in premenopausal and postmenopausal females.
Kalam F, Akasheh RT, Cienfuegos S, Ankireddy A, et al · · 2023 · cited 14× · PMID 36203273 · DOI 10.1002/oby.23562 -
Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach.
Brogi S, Tabanelli R, Puca S, Calderone V. · · 2024 · cited 11× · PMID 38998465 · DOI 10.3390/foods13131960 -
Changes in body weight and metabolic risk during time restricted feeding in premenopausal versus postmenopausal women.
Cienfuegos S, Gabel K, Kalam F, Ezpeleta M, et al · · 2021 · cited 10× · PMID 34478825 · DOI 10.1016/j.exger.2021.111545 -
Comparing caloric restriction regimens for effective weight management in adults: a systematic review and network meta-analysis.
Huang J, Li Y, Chen M, Cai Z, et al · · 2024 · cited 6× · PMID 39327619 · DOI 10.1186/s12966-024-01657-9
Verify or expand the search:
- PubMed search for NCT03867773
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Time restricted feeding
Trials testing the same drug.
- NCT05038137 — Time Restricted Eating on Cancer Risk · NA · completed
- NCT05593939 — Slow Age: Interventions to Slow Aging in Humans · Phase 2 · completed
- NCT05756868 — The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior · NA · completed
- NCT05717127 — Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes · NA · completed
- NCT04988230 — Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD ):a 12-month Follow-up Study · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other University of Illinois at Chicago trials
Trials by the same sponsor.
- NCT07498322 — Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System · NA · not yet recruiting
- NCT07387705 — On Track for Wellness (OTW) Stepped Wedge Cluster Randomized Trial · Phase 1 · not yet recruiting
- NCT07504120 — The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis · NA · not yet recruiting
- NCT07160582 — Cognitive-Motor Training for AD/ADRD Prevention · NA · not yet recruiting
- NCT07498348 — Apple Watch Evaluation of Endodontics Occupational Stress · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03867773 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Illinois at Chicago
- Last refreshed: 24 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03867773.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing